Saxenda Injection 6 1 Mg contains Liraglutide 6 mg/mL solution for injection in a pre-filled pen.

Used with a reduced-calorie eating plan and increased physical activity for weight management in eligible patients under medical supervision.

Inject under the skin once daily, at any time and preferably around the same time each day. Treatment usually starts at 0.6 mg daily and is increased gradually at weekly intervals to the prescribed target, up to 3 mg daily; follow the clinician’s titration plan and pen training.

Nausea, vomiting, diarrhoea, constipation and injection-site reactions are common, especially during dose escalation. Seek medical advice for persistent severe abdominal pain, repeated vomiting, dehydration or allergic reaction. Tell the prescriber about pancreatitis or gallbladder problems and other diabetes medicines.

This product information is for general reference and does not replace an individual assessment or advice from a qualified healthcare professional.